AI English summary of an SEC filing — figures as filed
Cigna CICigna said it entered into a share purchase agreement with Health Care Service Corporation (HCSC) on January 31, 2024 to sell its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D and CareAllies businesses for a total transaction value of approximately $3.7 billion.
Key points
AI summaryCigna said it entered into a share purchase agreement with Health Care Service Corporation (HCSC) on January 31, 2024 to sell its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D and CareAllies businesses for a total transaction value of approximately $3.7 billion.
The company said it expects to recognize an estimated pre-tax loss of $1.5 billion in net income as of December 31, 2023, primarily from asset write-offs and costs to sell. It said the loss will not affect adjusted income from operations for Q4 2023.
The company said it expects the transaction to close in Q1 2025, subject to regulatory approvals and other customary closing conditions. It also said there is no financing condition, and that Evernorth Health Services will continue to provide pharmacy benefit services to the Medicare businesses under a 4-year services agreement starting at closing.
Cigna reaffirmed its 2024 outlook of at least $28 in consolidated adjusted income from operations per share and its long-term annual adjusted EPS growth target of 10 to 13%. The company said it plans to allocate the majority of the proceeds to share repurchases after the sale is completed.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
HCSC to Acquire Medicare Businesses in $3.7 billion Deal
Cigna said it entered into a share purchase agreement with Health Care Service Corporation (HCSC) on January 31, 2024 to sell its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D and CareAllies businesses for a total transaction value of approximately $3.7 billion.
Source · Based on the filing body and exhibits
Pre-Tax Loss of $1.5 billion Expected, No Effect on Adjusted Operating Income
The company said it expects to recognize an estimated pre-tax loss of $1.5 billion in net income as of December 31, 2023, primarily from asset write-offs and costs to sell. It said the loss will not affect adjusted income from operations for Q4 2023.
Source · Based on the filing body and exhibits
Closing Timing and 4-Year Services Agreement
The company said it expects the transaction to close in Q1 2025, subject to regulatory approvals and other customary closing conditions. It also said there is no financing condition, and that Evernorth Health Services will continue to provide pharmacy benefit services to the Medicare businesses under a 4-year services agreement starting at closing.
Source · Based on the filing body and exhibits
Cigna Reaffirms 2024 Outlook and Sets Use of Sale Proceeds
Cigna reaffirmed its 2024 outlook of at least $28 in consolidated adjusted income from operations per share and its long-term annual adjusted EPS growth target of 10 to 13%. The company said it plans to allocate the majority of the proceeds to share repurchases after the sale is completed.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…